Direxion Daily S&P Biotech Bull 3X SharesLABU
LABU
0
Funds holding %
of 6,809 funds
–
Analysts bullish %
Fund manager confidence
Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)
86% more first-time investments, than exits
New positions opened: 13 | Existing positions closed: 7
60% more call options, than puts
Call options by funds: $123M | Put options by funds: $77.1M
17% more funds holding
Funds holding: 36 [Q2] → 42 (+6) [Q3]
0.16% less ownership
Funds ownership: 5.64% [Q2] → 5.48% (-0.16%) [Q3]
13% less capital invested
Capital invested by funds: $60M [Q2] → $51.9M (-$8.04M) [Q3]
59% less repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 17
Research analyst outlook
We haven’t received any recent analyst ratings for LABU.
Financial journalist opinion
Neutral
ETF Trends
1 week ago
There Could Be Value in Healthcare Stocks Ahead of 2025
When a new presidential administration is set to take office, there's uncertainty as to whether specific sectors could be impacted. In the case of healthcare, that's certainly the case, especially in biotech.
Neutral
ETF Trends
2 weeks ago
Top Performing Leveraged/Inverse ETFs: 12/01/2024
Top Performing Levered/Inverse ETFs Last Week These were last week's top-performing leveraged and inverse ETFs. Note that because of leverage, these kinds of funds can move quickly.
Positive
ETF Trends
4 months ago
Q2 Earnings Season Looms Large in Hopes for Broader Stocks Rally
Editor's note: Any and all references to time frames longer than one trading day are for purposes of market context only, and not recommendations of any holding time frame. Daily rebalancing ETFs are not meant to be held unmonitored for long periods.
Neutral
ETF Trends
4 months ago
Can Biotech Heal Itself?
Editor's note: Any and all references to time frames longer than one trading day are for purposes of market context only, and not recommendations of any holding time frame. Daily rebalancing ETFs are not meant to be held unmonitored for long periods.
Positive
ETF Trends
4 months ago
Top Performing Leveraged/Inverse ETFs: 07/28/2024
These were last week's top performing leveraged and inverse ETFs. Note that because of leverage, these kinds of funds can move quickly.
Positive
Zacks Investment Research
4 months ago
Best Inverse/Leveraged ETFs of Last Week
Wall Street offered a mixed performance last week.
Positive
Seeking Alpha
5 months ago
Buy LABU: Biotech Sector Benefits From Lower Interest Rates And AI
Seeking Alpha Quant rates LABU as a “HOLD”, but I rate it as a “BUY”. Markets expect the first interest rate cut at the September Fed meeting. LABU has strong momentum and benefits from lower interest rates.
Positive
ETF Trends
5 months ago
Top Performing Leveraged/Inverse ETFs: 07/14/2024
These were last week's top performing leveraged and inverse ETFs. Note that because of leverage, these kinds of funds can move quickly.
Positive
Zacks Investment Research
5 months ago
5 Top-Performing Inverse/Leveraged ETFs of Last Week
Wall Street was moderately upbeat last week.
Positive
ETF Trends
7 months ago
Top Performing Leveraged/Inverse ETFs: 05/05/2024
These were last week's top performing leveraged and inverse ETFs. Note that because of leverage, these kinds of funds can move quickly.
Charts implemented using Lightweight Charts™